Home >Medication Guide

Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Related Articles

  • Vericiguat(LuciVeric)

    Indicated to reduce the risk of cardiovascular death and heart failure hospitalization in adult patients with symptomatic chronic heart failure and ejection fraction less than 45% ···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:3

  • Brensocatib(LuciBren)

    Brensocatib is indicated for the treatment of non-cystic fibrosis bronchiectasis (NCFB) in adult and pediatric patients 12 years of age and older.【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

  • Zongertinib(LuciZonger)

    for adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating mutations in the HER2 (ERBB2) tyrosine kinase domain.【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

  • Mirogabalin(LuciMirog)

    neuropathic pain【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

  • Atrasentan(LuciAtras)

    Atrasentan is indicated to reduce proteinuria in adult patients with primary immunoglobulin A nephropathy (IgAN) who are at risk of rapid disease progression, generally defined as ···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:3

  • Talazoparib(LuciTala)

    As monotherapy for adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), HER2-negative locally advanced or metastatic breast cancer; in combinati···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

  • Bedaquiline(LuciBeda)

    Bedaquiline, as part of combination therapy, is indicated for the treatment of pulmonary tuberculosis (TB) in adult and pediatric patients (2 years of age and older and weighing at···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:3

  • Acoramidis(LuciAcor)

    Indicated for adult patients with wild-type or variant transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) to reduce cardiovascular death and cardiovascular-related hospitaliza···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:5

  • Pazopanib(LUCiPazo)

    Pazopanib (LUCiPazo) is indicated for adult patients with advanced renal cell carcinoma (RCC) and adult patients with advanced soft tissue sarcoma (STS) who have previously receive···【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:3

  • Ripretinib(LuciRip)

    For adult patients with advanced gastrointestinal stromal tumors (GIST) who have previously received 3 or more kinase inhibitors, including imatinib.【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:3

  • Tenapanor(LuciTena)

    Tenapanor (LuciTena) is indicated to reduce serum phosphorus levels in adult patients with chronic kidney disease (CKD) receiving dialysis.【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

  • Nirogacestat(LuciNiro)

    Nirogacestat (LuciNiro) is indicated for adult patients with progressing desmoid tumors who require systemic therapy.【more】
    Article source:Captain MedicineRelease date:2026-10-21Recommended:4

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Contact US

Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

  • Whatsapp

    Name: Lucius

  • Telegram name: Vira

    No.:0085253923643

Lucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved Lucius Pharmaceuticals Lucius Laos 老挝全球药房

WhatsApp

Telegram name: Vira

No.:0085253923643